REPORTS

Let’s Pullulate and Expand Your Business

Global Gastric Motility Disorder Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Mar 29, 2020  |  146 PAGES  |  REPORT CODE: CMM274415
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Gastric Motility Disorder Drug is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period. The research provides insights for the global Gastric Motility Disorder Drug market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Gastric Motility Disorder Drug industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Gastric Motility Disorder Drug Market Segmentations:

By Players:

  • Concert Pharmaceuticals, Inc.

  • Helsinn Healthcare S.A.

  • ChironWells GmbH

  • Targacept, Inc.

  • Theravance, Inc.

By Types:

  • Velusetrag

  • Ipamorelin

  • TD-8954

  • Others

By End-User:

  • Hospital

  • Clinic

  • Home Use

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastric Motility Disorder Drug Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Gastric Motility Disorder Drug Market Share by Types

    • 1.3.2 Global Gastric Motility Disorder Drug Market Size and Growth Rate of Velusetrag from 2014 to 2026

    • 1.3.3 Global Gastric Motility Disorder Drug Market Size and Growth Rate of Ipamorelin from 2014 to 2026

    • 1.3.4 Global Gastric Motility Disorder Drug Market Size and Growth Rate of TD-8954 from 2014 to 2026

    • 1.3.5 Global Gastric Motility Disorder Drug Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Gastric Motility Disorder Drug Market Share by End-Users

    • 1.4.2 Global Gastric Motility Disorder Drug Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.3 Global Gastric Motility Disorder Drug Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.4.4 Global Gastric Motility Disorder Drug Market Size and Growth Rate of Home Use from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Gastric Motility Disorder Drug Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Gastric Motility Disorder Drug by Major Types

    • 3.4.1 Market Size and Growth Rate of Velusetrag

    • 3.4.2 Market Size and Growth Rate of Ipamorelin

    • 3.4.3 Market Size and Growth Rate of TD-8954

    • 3.4.4 Market Size and Growth Rate of Others

4 Segmentation of Gastric Motility Disorder Drug Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Gastric Motility Disorder Drug by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Gastric Motility Disorder Drug for Hospital

    • 4.4.2 Market Size and Growth Rate of Gastric Motility Disorder Drug for Clinic

    • 4.4.3 Market Size and Growth Rate of Gastric Motility Disorder Drug for Home Use

5 Market Analysis by Major Regions

  • 5.1 Global Gastric Motility Disorder Drug Production Analysis by Major Regions

  • 5.2 Global Gastric Motility Disorder Drug Consumption Analysis by Major Regions

  • 5.3 Global Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

6 Product Commodity of Gastric Motility Disorder Drug Market in Major Countries

  • 6.1 Top 5 Export Countries in Gastric Motility Disorder Drug market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Gastric Motility Disorder Drug market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Gastric Motility Disorder Drug market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Gastric Motility Disorder Drug market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Gastric Motility Disorder Drug market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Gastric Motility Disorder Drug market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Gastric Motility Disorder Drug Landscape Analysis

  • 7.1 North America Gastric Motility Disorder Drug Landscape Analysis by Major Types

  • 7.2 North America Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

  • 7.3 North America Gastric Motility Disorder Drug Landscape Analysis by Major Countries

    • 7.3.1 United States Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 7.3.2 Canada Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 7.3.3 Mexico Gastric Motility Disorder Drug Market Volume and Growth Rate

8 Europe Gastric Motility Disorder Drug Landscape Analysis

  • 8.1 Europe Gastric Motility Disorder Drug Landscape Analysis by Major Types

  • 8.2 Europe Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

  • 8.3 Europe Gastric Motility Disorder Drug Landscape Analysis by Major Countries

    • 8.3.1 Germany Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 8.3.2 UK Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 8.3.3 France Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 8.3.4 Italy Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 8.3.6 Spain Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 8.3.7 Belgium Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 8.3.8 Poland Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 8.3.9 Russia Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 8.3.10 Turkey Gastric Motility Disorder Drug Market Volume and Growth Rate

9 Asia Pacific Gastric Motility Disorder Drug Landscape Analysis

  • 9.1 Asia Pacific Gastric Motility Disorder Drug Landscape Analysis by Major Types

  • 9.2 Asia Pacific Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Gastric Motility Disorder Drug Landscape Analysis by Major Countries

    • 9.3.1 China Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 9.3.2 Japan Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 9.3.4 India Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 9.3.6 South Korea Gastric Motility Disorder Drug Market Volume and Growth Rate

10 Latin America, Middle East & Africa Gastric Motility Disorder Drug Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Gastric Motility Disorder Drug Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Gastric Motility Disorder Drug Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 10.3.2 Brazil Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 10.3.3 Nigeria Gastric Motility Disorder Drug Market Volume and Growth Rate

    • 10.3.4 South Africa Gastric Motility Disorder Drug Market Volume and Growth Rate 

    • 10.3.5 Argentina Gastric Motility Disorder Drug Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Concert Pharmaceuticals, Inc.

    • 11.1.1 Concert Pharmaceuticals, Inc. Company Profile and Development Status

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Helsinn Healthcare S.A.

    • 11.2.1 Helsinn Healthcare S.A. Company Profile and Development Status

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 ChironWells GmbH

    • 11.3.1 ChironWells GmbH Company Profile and Development Status

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Targacept, Inc.

    • 11.4.1 Targacept, Inc. Company Profile and Development Status

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Theravance, Inc.

    • 11.5.1 Theravance, Inc. Company Profile and Development Status

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 82 Figures and 157 Tables)

  • Figure Product Picture

  • Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of Velusetrag from 2014 to 2026

  • Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of Ipamorelin from 2014 to 2026

  • Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of TD-8954 from 2014 to 2026

  • Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of Hospital from 2014 to 2026

  • Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of Clinic from 2014 to 2026

  • Figure Global Gastric Motility Disorder Drug Market Size and Growth Rate of Home Use from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Gastric Motility Disorder Drug Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Gastric Motility Disorder Drug Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Gastric Motility Disorder Drug

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Gastric Motility Disorder Drug by Different Types from 2014 to 2026

  • Table Consumption Share of Gastric Motility Disorder Drug by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Velusetrag

  • Figure Market Size and Growth Rate of Ipamorelin

  • Figure Market Size and Growth Rate of TD-8954

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Gastric Motility Disorder Drug by Different End-Users from 2014 to 2026

  • Table Consumption Share of Gastric Motility Disorder Drug by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Hospital

  • Figure Market Size and Growth Rate of Clinic

  • Figure Market Size and Growth Rate of Home Use

  • Table Global Gastric Motility Disorder Drug Production by Major Regions

  • Table Global Gastric Motility Disorder Drug Production Share by Major Regions

  • Figure Global Gastric Motility Disorder Drug Production Share by Major Regions in 2014

  • Figure Global Gastric Motility Disorder Drug Production Share by Major Regions in 2018

  • Figure Global Gastric Motility Disorder Drug Production Share by Major Regions in 2026

  • Table Global Gastric Motility Disorder Drug Consumption by Major Regions

  • Table Global Gastric Motility Disorder Drug Consumption Share by Major Regions

  • Figure Global Gastric Motility Disorder Drug Consumption Share by Major Regions in 2014

  • Figure Global Gastric Motility Disorder Drug Consumption Share by Major Regions in 2018

  • Figure Global Gastric Motility Disorder Drug Consumption Share by Major Regions in 2026

  • Table North America Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

  • Table Europe Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Gastric Motility Disorder Drug market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Gastric Motility Disorder Drug market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Gastric Motility Disorder Drug market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Gastric Motility Disorder Drug market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

  • Table North America Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

  • Figure North America Gastric Motility Disorder Drug Consumption Share by Types in 2014

  • Figure North America Gastric Motility Disorder Drug Consumption Share by Types in 2018

  • Figure North America Gastric Motility Disorder Drug Consumption Share by Types in 2026

  • Table North America Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

  • Table North America Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

  • Figure North America Gastric Motility Disorder Drug Consumption Share by End-Users in 2014

  • Figure North America Gastric Motility Disorder Drug Consumption Share by End-Users in 2018

  • Figure North America Gastric Motility Disorder Drug Consumption Share by End-Users in 2026

  • Table North America Gastric Motility Disorder Drug Consumption by Major Countries from 2014 to 2026

  • Table North America Gastric Motility Disorder Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Gastric Motility Disorder Drug Consumption Share by Major Countries in 2014

  • Figure North America Gastric Motility Disorder Drug Consumption Share by Major Countries in 2018

  • Figure North America Gastric Motility Disorder Drug Consumption Share by Major Countries in 2026

  • Figure United States Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

  • Table Europe Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

  • Figure Europe Gastric Motility Disorder Drug Consumption Share by Types in 2014

  • Figure Europe Gastric Motility Disorder Drug Consumption Share by Types in 2018

  • Figure Europe Gastric Motility Disorder Drug Consumption Share by Types in 2026

  • Table Europe Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

  • Table Europe Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Gastric Motility Disorder Drug Consumption Share by End-Users in 2014

  • Figure Europe Gastric Motility Disorder Drug Consumption Share by End-Users in 2018

  • Figure Europe Gastric Motility Disorder Drug Consumption Share by End-Users in 2026

  • Table Europe Gastric Motility Disorder Drug Consumption by Major Countries from 2014 to 2026

  • Table Europe Gastric Motility Disorder Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Gastric Motility Disorder Drug Consumption Share by Major Countries in 2014

  • Figure Europe Gastric Motility Disorder Drug Consumption Share by Major Countries in 2018

  • Figure Europe Gastric Motility Disorder Drug Consumption Share by Major Countries in 2026

  • Figure Germany Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure France Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

  • Table Asia Pacific Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Gastric Motility Disorder Drug Consumption Share by Types in 2014

  • Figure Asia Pacific Gastric Motility Disorder Drug Consumption Share by Types in 2018

  • Figure Asia Pacific Gastric Motility Disorder Drug Consumption Share by Types in 2026

  • Table Asia Pacific Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Gastric Motility Disorder Drug Consumption Share by End-Users in 2014

  • Figure Asia Pacific Gastric Motility Disorder Drug Consumption Share by End-Users in 2018

  • Figure Asia Pacific Gastric Motility Disorder Drug Consumption Share by End-Users in 2026

  • Table Asia Pacific Gastric Motility Disorder Drug Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Gastric Motility Disorder Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Gastric Motility Disorder Drug Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Gastric Motility Disorder Drug Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Gastric Motility Disorder Drug Consumption Share by Major Countries in 2026

  • Figure China Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandGastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure India Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Gastric Motility Disorder Drug Consumption Share by Major Countries in 2026

  • Figure GCC Countries Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Concert Pharmaceuticals, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Concert Pharmaceuticals, Inc.

  • Figure Sales and Growth Rate Analysis of Concert Pharmaceuticals, Inc.

  • Figure Revenue and Market Share Analysis of Concert Pharmaceuticals, Inc.

  • Table Product and Service Introduction of Concert Pharmaceuticals, Inc.

  • Table Company Profile and Development Status of Helsinn Healthcare S.A.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Helsinn Healthcare S.A.

  • Figure Sales and Growth Rate Analysis of Helsinn Healthcare S.A.

  • Figure Revenue and Market Share Analysis of Helsinn Healthcare S.A.

  • Table Product and Service Introduction of Helsinn Healthcare S.A.

  • Table Company Profile and Development Status of ChironWells GmbH

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ChironWells GmbH

  • Figure Sales and Growth Rate Analysis of ChironWells GmbH

  • Figure Revenue and Market Share Analysis of ChironWells GmbH

  • Table Product and Service Introduction of ChironWells GmbH

  • Table Company Profile and Development Status of Targacept, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Targacept, Inc.

  • Figure Sales and Growth Rate Analysis of Targacept, Inc.

  • Figure Revenue and Market Share Analysis of Targacept, Inc.

  • Table Product and Service Introduction of Targacept, Inc.

  • Table Company Profile and Development Status of Theravance, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Theravance, Inc.

  • Figure Sales and Growth Rate Analysis of Theravance, Inc.

  • Figure Revenue and Market Share Analysis of Theravance, Inc.

  • Table Product and Service Introduction of Theravance, Inc.


Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top